Publications by authors named "Giovannini-Chami L"

Article Synopsis
  • The study aimed to analyze characteristics of healthy children with obstructive sleep apnea (OSA-I) and those with OSA and non-syndromic obesity (OSA-II) in France who were treated with CPAP or NIV in 2019.
  • Data from a national survey focused on CPAP/NIV initiation criteria, duration, age at initiation, equipment used, settings, and compliance were examined.
  • Results showed that OSA-II patients were older at initiation and treated longer than OSA-I patients, with both groups mainly using CPAP, but having similar compliance rates.
View Article and Find Full Text PDF
Article Synopsis
  • A study examined the prevalence and incidence of interstitial lung disease in children (chILD) in France, finding it affects 44 children per million in 2022 and has an incidence of 4.4 per million.
  • The research included data from 790 patients across 42 centers, noting that the median age for diagnosis was 3 months, with a significant portion having familial forms.
  • Management typically involved oxygen therapy and corticosteroids, with survival rates being 57.3% for children diagnosed before 2 years and 86% for those diagnosed between 2 and 18 years; the study highlights the need for improved international data collection and standardized practices.
View Article and Find Full Text PDF

Background: Airway clearance (ACT) and lung volume recruitment (LVR) techniques are used to manage bronchial secretions, increase cough efficiency and lung/chest wall recruitment, to prevent and treat respiratory tract infections. The aim of the study was to review the prescription of ACT/LVR techniques for home use in children in France.

Methods: All the centers of the national pediatric noninvasive ventilation (NIV) network were invited to fill in an anonymous questionnaire for every child aged ≤20 years who started a treatment with an ACT/LVR device between 2022 and 2023.

View Article and Find Full Text PDF

Introduction: Periodic breathing (PB) is considered physiological in the neonatal period and usually disappears in the first months of life. There are few data available on persistent PB after the neonatal period. The objective of this study was to characterize infants born at term with persistent PB after the age of 1 month through polysomnography (PSG) performed during symptoms.

View Article and Find Full Text PDF

Background: It is unclear whether sensitization patterns differentiate children with severe recurrent wheeze (SRW)/severe asthma (SA) from those with non-severe recurrent wheeze (NSRW)/non-severe asthma (NSA). Our objective was to determine whether sensitization patterns can discriminate between children from the French COBRAPed cohort with NSRW/NSA and those with SRW/SA.

Methods: IgE to 112 components (c-sIgE) (ImmunoCAP® ISAC) were analyzed in 125 preschools (3-6 years) and 170 school-age children (7-12 years).

View Article and Find Full Text PDF

Introduction: Despite evidence of the benefits of the written asthma action plans (WAP) in asthma control, they remain poorly applied. The aim of our study was to assess the practices of French-speaking pulmonologists and paediatricians in their use of WAP for asthma control and to analyse the contents of several WAPs routinely consulted in treatment of asthma patients.

Methods: Members of three French medical societies (SPLF, G2A, SP2A) were requested to share their WAPs for asthma patients and to participate in an online survey about the possible influence of these documents on their practices.

View Article and Find Full Text PDF

Background: Cardiac involvement is central in MIS-C and represents the main cause of morbidity. In this study, we aimed to assess myocardial damage in patients with MIS-C using cardiac magnetic resonance (CMR) during the acute phase, as well as left ventricular and atrial longitudinal strain on admission, at discharge, and after 3 months.

Methods: We performed a single-center prospective cohort study and case-control study.

View Article and Find Full Text PDF

Background: No approved treatment for peanut allergy exists for children younger than 4 years of age, and the efficacy and safety of epicutaneous immunotherapy with a peanut patch in toddlers with peanut allergy are unknown.

Methods: We conducted this phase 3, multicenter, double-blind, randomized, placebo-controlled trial involving children 1 to 3 years of age with peanut allergy confirmed by a double-blind, placebo-controlled food challenge. Patients who had an eliciting dose (the dose necessary to elicit an allergic reaction) of 300 mg or less of peanut protein were assigned in a 2:1 ratio to receive epicutaneous immunotherapy delivered by means of a peanut patch (intervention group) or to receive placebo administered daily for 12 months.

View Article and Find Full Text PDF

The aim of the study was to describe the characteristics of children with neuromuscular diseases treated with long term noninvasive ventilation or continuous positive airway pressure in France. On June 1st 2019, 387 patients (63% boys, mean age 11.2 ± 5.

View Article and Find Full Text PDF
Article Synopsis
  • - The COMSA Working Group developed standardized Core Outcome Measures (COM) sets for assessing the effectiveness of biological therapies in treating severe asthma in both adults and children to improve data synthesis and evaluation.
  • - A collaborative approach involved patients, clinicians, and health regulators across Europe, using extensive evidence reviews and surveys to shape the outcome measures, which include key metrics like forced expiratory volume (FEV) and frequency of severe exacerbations.
  • - The resulting COM sets aim to enhance future clinical trial methodologies, improve comparability of treatment outcomes, and provide a framework for understanding responses to biological therapies in severe asthma.
View Article and Find Full Text PDF

Background: In 2014, germline signal transducer and activator of transcription (STAT) 3 gain-of-function (GOF) mutations were first described to cause a novel multisystem disease of early-onset lymphoproliferation and autoimmunity.

Objective: This pivotal cohort study defines the scope, natural history, treatment, and overall survival of a large global cohort of patients with pathogenic STAT3 GOF variants.

Methods: We identified 191 patients from 33 countries with 72 unique mutations.

View Article and Find Full Text PDF

Background: ROHHAD syndrome (Rapid-onset Obesity with Hypothalamic dysfunction, Hypoventilation and Autonomic Dysregulation) is rare. Rapid-onset morbid obesity is usually the first recognizable sign of this syndrome, however a subset of patients develop ROHHAD syndrome without obesity. The prevalence of this entity is currently unknown.

View Article and Find Full Text PDF

Introduction: Bier anemic spots, cyanosis, and urticaria-like eruption (BASCULE) syndrome is an underreported pediatric vascular disorder from the group of acrosyndromes. In children, these include paroxysmal acrosyndromes (Raynaud's phenomenon and chilblain-like lesions), permanent acrosyndromes (acrocyanosis), and transient acrosyndromes, in which their pathogeneses are associated with virus infections, Epstein-Barr virus, and, more recently, SARS-CoV-2, respectively.

Methods: We reported a case of BASCULE syndrome associated with postural orthostatic tachycardia syndrome (POTS) and provided a narrative review of case reports describing the BASCULE syndrome in children.

View Article and Find Full Text PDF

Background: Food allergy is a potentially life-threatening disease, affecting up to 10% of the pediatric population.

Objective: The aim of our study was to assess the health-related quality of life (HRQL) of food-allergic patients compared with the general population and patients with other chronic diseases with dietary or allergic burden, in a cross-sectional study.

Methods: We recruited patients aged 8-17 years diagnosed with food allergy and matched healthy controls recruited in schools.

View Article and Find Full Text PDF

Introduction: At the end of April 2020, three European pediatric societies published an alert on a new hyperinflammatory disorder linked to SARS-CoV-2. This disease has alternatively been called Kawasaki-like disease, pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS), and multisystem inflammatory syndrome in children (MIS-C). These alerts provide a clear starting point from which to study the early response of the medical and scientific community to a new disease in terms of scientific publications, and to compare the timeline of this response with levels of general public interest.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess how children perceive the coronavirus SARS-CoV-2 by examining their drawings and recognition of the virus in images.
  • - Researchers involved 103 French children aged 5 to 17, finding that while most depicted the virus circularly with a crownlike feature, some added imaginative, anthropomorphic elements to their drawings.
  • - Overall, the children showed a relatively accurate understanding of SARS-CoV-2, highlighting their ability to cope with the virus's representation through less frightening and more colorful artistic expressions than might be expected.
View Article and Find Full Text PDF